Efficacy of Extracorporeal Shockwave Therapy (ESWT) on symptomatic knee osteoarthritis: A randomized double blinded (patient and assessor) controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20170829001

Enrollment

Registered

2017-08-29

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis Knee osteoarthritis Extracorporeal shockwave therapy Visual analogue scale The Western Ontario and McMaster Univerdities Osteoarthritis Index

Interventions

Focus ESWT with probe sized 20 mm in diameters with frequency 8 Hz and intensity stages as toleration of individual participants but not more than 15 steps.Between metal and silicone probe was put wit

Active Comparator Procedure/Surgery,Sham Comparator Procedure/Surgery

fESWT,sham

Eligibility

Sex/Gender

All

Age

50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.OA knee was diagnose by ACR 1986 2.K-L grade 2-3 3.VAS at least 4 4.inforn and consent 5.BMI less than 29.99

Exclusion criteria

Exclusion criteria: 1.knee pain from other condition such as tendinitis 2.systemic arthritis 3.cerebrovascular disease 4.neuromuscular disease 5.history of surgery or traumatic knee 6.paracetamol allergy 7.history of treatment with physical modalities, medication or injection less than 6 months 8.skin conditions such as infection, echymosis 9.impaired cognition 10.history of tretment with ESWT

Design outcomes

Primary

Measure	Time frame
VAS 8 weeks Questionaire	—

Secondary

Measure	Time frame
WOMAC 8 weeks Questionaire	—

Countries

Thailand

Contacts

Public ContactAreerat Suputtitada

Pain research

prof.areerat@gmail.com66814888549

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026